Ardelyx, Inc.

NasdaqGM:ARDX Rapport sur les actions

Capitalisation boursière : US$1.3b

Ardelyx Gestion

Gestion contrôle des critères 3/4

Le PDG Ardelyx est Mike Raab, nommé en Mar2009, a un mandat de 15.67 ans. La rémunération annuelle totale est $ 4.12M, composée du salaire de 17% et des bonus 83%, y compris les actions et options de la société. détient directement 0.52% des actions de la société, d'une valeur de $ 6.55M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.2 ans et 9.1 ans.

Informations clés

Mike Raab

Directeur général

US$4.1m

Rémunération totale

Pourcentage du salaire du PDG17.0%
Durée du mandat du directeur général15.7yrs
Propriété du PDG0.5%
Durée moyenne d'occupation des postes de direction4.2yrs
Durée moyenne du mandat des membres du conseil d'administration9.1yrs

Mises à jour récentes de la gestion

Recent updates

Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It

Nov 24

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability

Nov 14

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Nov 03
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business

Oct 24
Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business

Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?

Aug 25
Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?

Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Aug 07
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Ardelyx Faces Rising Challenges Despite Revenue Growth

Aug 05

Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 04
Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook

Jul 13

Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge

Jul 05
Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge

Ardelyx: Strong Execution, Fairly Valued

May 10

Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

May 04
Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)

May 03

Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing

Apr 17
Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing

Ardelyx Shrugs Off 'Mixed' Q4 Earnings

Mar 13

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Feb 24
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance

Feb 20

Ardelyx's XPHOZAH Still An Afterthought To The Pros

Jan 31

Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement

Jan 10

Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price

Jan 04
Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price

Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt

Dec 14
Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt

Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Aug 03
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt

Jul 31
Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt

Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now

Apr 17
Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now

Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Mar 30
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Dec 14
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

What To Expect For Ardelyx In The Coming Month

Oct 18

Analyse de la rémunération des PDG

Comment la rémunération de Mike Raab a-t-elle évolué par rapport aux bénéfices de Ardelyx?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

-US$73m

Jun 30 2024n/an/a

-US$65m

Mar 31 2024n/an/a

-US$66m

Dec 31 2023US$4mUS$700k

-US$66m

Sep 30 2023n/an/a

-US$27m

Jun 30 2023n/an/a

-US$56m

Mar 31 2023n/an/a

-US$66m

Dec 31 2022US$2mUS$650k

-US$67m

Sep 30 2022n/an/a

-US$114m

Jun 30 2022n/an/a

-US$135m

Mar 31 2022n/an/a

-US$153m

Dec 31 2021US$4mUS$650k

-US$158m

Sep 30 2021n/an/a

-US$151m

Jun 30 2021n/an/a

-US$125m

Mar 31 2021n/an/a

-US$105m

Dec 31 2020US$4mUS$633k

-US$94m

Sep 30 2020n/an/a

-US$85m

Jun 30 2020n/an/a

-US$91m

Mar 31 2020n/an/a

-US$91m

Dec 31 2019US$2mUS$595k

-US$95m

Sep 30 2019n/an/a

-US$103m

Jun 30 2019n/an/a

-US$104m

Mar 31 2019n/an/a

-US$100m

Dec 31 2018US$4mUS$575k

-US$91m

Sep 30 2018n/an/a

-US$53m

Jun 30 2018n/an/a

-US$50m

Mar 31 2018n/an/a

-US$53m

Dec 31 2017US$5mUS$555k

-US$64m

Rémunération vs marché: La rémunération totale de Mike ($USD 4.12M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 5.50M ).

Rémunération et revenus: La rémunération de Mike a augmenté alors que l'entreprise n'est pas rentable.

PDG

Mike Raab (59 yo)

15.7yrs

Titularisation

US$4,118,144

Compensation

Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Michael Raab
President15.7yrsUS$4.12m0.52%
$ 6.5m
Elizabeth Grammer
Chief Legal & Administrative Officer and Secretary10.5yrsUS$1.63m0.081%
$ 1.0m
Laura Williams
Chief Medical Officer4yrsUS$1.63m0.13%
$ 1.7m
Justin Renz
Chief Financial & Operations Officer4.4yrsUS$1.73m0.12%
$ 1.6m
Joseph Reilly
Senior VP of Finance & Principal Accounting Officerno datapas de données0.051%
$ 637.1k
Caitlin Lowie
Vice President of Corporate Communications & Investor Relationsno datapas de donnéespas de données
Mike Kelliher
Executive Vice President of Corporate Development & Strategyless than a yearpas de donnéespas de données
Charon Spencer
Chief Human Resources Officer1.8yrspas de donnéespas de données
David Rosenbaum
Chief Development Officer9.8yrsUS$1.63m0.23%
$ 2.8m
Robert Blanks
Chief Regulatory Affairs & Quality Assurance Officerno dataUS$1.70m0.13%
$ 1.7m
Susan Rodriguez
Advisor4.5yrsUS$1.04m0.19%
$ 2.4m
Eric Foster
Chief Commercial Officerless than a yearpas de donnéespas de données

4.2yrs

Durée moyenne de l'emploi

60yo

Âge moyen

Gestion expérimentée: L'équipe de direction de ARDX est considérée comme expérimentée (ancienneté moyenne 4.2 ans).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Michael Raab
President15.7yrsUS$4.12m0.52%
$ 6.5m
David Mott
Independent Chairman of the Board15.7yrsUS$249.90k0.60%
$ 7.6m
William C. Bertrand
Independent Director9.1yrsUS$214.90k0.097%
$ 1.2m
Richard Rodgers
Independent Director10.7yrsUS$222.40k0.11%
$ 1.3m
Robert Bazemore
Independent Director8.4yrsUS$202.40kpas de données
Onaiza Cadoret-Manier
Independent Director4.7yrsUS$199.90k0.047%
$ 585.0k
Muna Bhanji
Independent Director3.7yrsUS$202.40k0.040%
$ 508.7k

9.1yrs

Durée moyenne de l'emploi

59yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de ARDX sont considérés comme expérimentés (ancienneté moyenne 9.1 ans).